In Vitro Microfluidic Models for Neurodegenerative Disorders.

Area of Science:

• Biomedical Engineering
• Neuroscience
• Drug Discovery

Background:

• Neurodegenerative diseases pose significant challenges in understanding pathophysiology and developing treatments.
• Traditional in vitro models (e.g., 2D cultures) have limitations in recapitulating complex biological systems.
• Microfluidic devices offer advanced capabilities for creating biomimetic cellular microenvironments.

Purpose of the Study:

• To review recent advancements in microfluidic organ-on-a-chip models for neurodegenerative diseases.
• To highlight the advantages of microfluidics in simulating in vivo conditions for central and peripheral nervous systems.
• To discuss current limitations and future strategies for these models.

Main Methods:

• Utilizing microfluidic devices to create compartmentalized cell culture microenvironments.
• Co-culturing neurons, glial cells, endothelial cells, and skeletal muscle cells.
• Recreating spatiotemporal chemical gradients and mechanical microenvironments relevant to neurodegenerative disease pathophysiology.

Main Results:

• Demonstrated successful modeling of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
• Highlighted the ability of microfluidic systems to mimic critical features of disease progression in vitro.
• Emphasized the potential of these systems to reduce reliance on animal testing.

Conclusions:

• Microfluidic organ-on-a-chip technology provides a powerful platform for studying neurodegenerative diseases.
• These advanced in vitro models can accelerate drug discovery and toxicological studies.
• Further development can overcome current drawbacks, significantly minimizing animal testing in preclinical research.